Topics
Bill Information
Summary
Bill Summary
US HR 89, the Prescription Freedom Act of 2025, would repeal the FDA's authority to mandate prescription requirements for drugs by eliminating subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act. The bill would transfer regulatory control over drug dispensing from the federal level to individual states, allowing each state to determine its own prescription requirements based on state law. An exception preserves federal prescription authority only for drugs intended to terminate pregnancies. The repeal would take effect a specified number of months after enactment, fundamentally shifting how Americans access medications.
Why It Matters to MAHA
MAHA strongly supports this bill because it embodies core principles of health freedom and patient autonomy by removing federal barriers to medication access. The current FDA prescription mandate restricts patients' ability to obtain treatments they may need without doctor approval, limiting choice and creating unnecessary bureaucratic obstacles. By devolving authority to states, the bill respects federalism and allows communities to craft drug access policies tailored to their populations' needs and values. This aligns with MAHA's commitment to reducing regulatory paternalism and trusting individuals and states rather than distant federal agencies to make healthcare decisions. Expanding access to medications enhances patient choice and supports innovation in how treatments reach those who need them.
Sponsor

Andy Biggs
Republican Representative (US)